Both the increased GRP78 expression in RPMI8226 and the increased p-eIF2α in the early phase and the following decrease of it in the late phase in response to BTZ with CAM treatments, suggest enhanced ER stress loading in MM cells. The gene discussed is EIF2A; the disease is Miyoshi myopathy.